Literature DB >> 30684657

Hot melt extrusion technology for improved dissolution, solubility and "spring-parachute" processes of amorphous self-micellizing solid dispersions containing BCS II drugs indomethacin and fenofibrate: Profiles and mechanisms.

Nian-Qiu Shi1, Shu-Ran Wang2, Yong Zhang3, Jun-Shuang Huo2, Li-Na Wang4, Jian-Hui Cai5, Zheng-Qiang Li6, Bai Xiang7, Xian-Rong Qi8.   

Abstract

Many strategies have been employed to improve oral drug delivery. One such approach involves the use of supersaturable delivery systems such as amorphous self-micellizing solid dispersions (SmSDs). SmSDs have attracted more attention recently, but little is known regarding the impact of production methods on profiles and internal mechanisms of final SmSDs in spite of its importance. In this study, amorphous SmSDs containing self-micellizing Soluplus® and BCS II drug (either indomethacin (IND) or fenofibrate (FEN)) were generated using various methods: solvent evaporation (SOL), freeze-drying (FD), microwave radiation-quench cooling (MQC), and hot melt extrusion (HME). Microscopic morphology, amorphous state, thermal behavior, dissolution/solubility, and "spring-parachute" data were used to assemble physicochemical profiles for SmSD systems prepared using each method. Analysis of intermolecular interactions, solubilization, and crystallization inhibition further uncovered internal mechanisms explaining observed physicochemical properties. Generally, SmSD/IND and SmSD/FEN systems generated using HME exhibited superior dissolution, solubility, and spring-parachute profiles. The superior advantages of HME-generated SmSD/IND systems were attributed to relatively stronger intermolecular interactions than observed in SmSD/IND systems fabricated using other methods. Moreover, self-micellizing Soluplus® carrier was able to solubilize IND or FEN and suppress drug crystallization from a supersaturated state, which seemed to be an important mechanism for the properties enhancement caused by SmSD/FENHME. This knowledge should be useful for guiding further development of self-micellizing solid dispersions and for gaining deeper understanding of how HME technology can improve supersaturable drug delivery based on SmSDs strategy.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Dissolution/solubility; Hot melt extrusion (HME); Manufacturing methods; Molecular mechanisms; Self-micellizing solid dispersions (SmSD)

Mesh:

Substances:

Year:  2019        PMID: 30684657     DOI: 10.1016/j.ejps.2019.01.019

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

1.  Sustainable Dissolution Performance of a Carrier Tailored Electrospun.

Authors:  Xin-Yi Teoh; Yuyu Yeoh; Lai-Keng Yoong; Siok-Yee Chan
Journal:  Pharm Res       Date:  2020-01-07       Impact factor: 4.200

Review 2.  An update on the contribution of hot-melt extrusion technology to novel drug delivery in the twenty-first century: part II.

Authors:  Sandeep Sarabu; Suresh Bandari; Venkata Raman Kallakunta; Roshan Tiwari; Hemlata Patil; Michael A Repka
Journal:  Expert Opin Drug Deliv       Date:  2019-05-14       Impact factor: 6.648

3.  Preparation and Characterization of pH-Independent Sustained-Release Tablets Containing Hot Melt Extruded Solid Dispersions of Clarithromycin : Tablets Containing Solid Dispersions of Clarithromycin.

Authors:  Qazi Amir Ijaz; Sumera Latif; Qurat-Ul-Ain Shoaib; Memoona Rashid; Muhammad Sohail Arshad; Amjad Hussain; Nadeem Irfan Bukhari; Sohail Riaz; Nasir Abbas
Journal:  AAPS PharmSciTech       Date:  2021-11-12       Impact factor: 3.246

Review 4.  Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions.

Authors:  Amritha G Nambiar; Maan Singh; Abhishek R Mali; Dolores R Serrano; Rajnish Kumar; Anne Marie Healy; Ashish Kumar Agrawal; Dinesh Kumar
Journal:  AAPS PharmSciTech       Date:  2022-09-02       Impact factor: 4.026

5.  Self-Micellizing Technology Improves the Properties of Ezetimibe and Increases Its Effect on Hyperlipidemic Rats.

Authors:  Carlos Torrado-Salmerón; Víctor Guarnizo-Herrero; Javier Cerezo-Garreta; Guillermo Torrado Durán; Santiago Torrado-Santiago
Journal:  Pharmaceutics       Date:  2019-12-03       Impact factor: 6.321

6.  Soluplus-Mediated Diosgenin Amorphous Solid Dispersion with High Solubility and High Stability: Development, Characterization and Oral Bioavailability.

Authors:  Pei Liu; Jian-Yu Zhou; Jin-Hua Chang; Xi-Gang Liu; He-Fei Xue; Ru-Xing Wang; Zhong-Si Li; Chun-Shi Li; Jian Wang; Cui-Zhe Liu
Journal:  Drug Des Devel Ther       Date:  2020-07-27       Impact factor: 4.162

7.  Hot liquid extrusion assisted drug-cyclodextrin complexation: a novel continuous manufacturing method for solubility and bioavailability enhancement of drugs.

Authors:  Alekhya Sri Nagini Manne; Aswathi R Hegde; Sushil Yadaorao Raut; Rajat Radhakrishna Rao; Vijay Induvadan Kulkarni; Srinivas Mutalik
Journal:  Drug Deliv Transl Res       Date:  2020-09-21       Impact factor: 4.617

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.